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T he past few years have witnessed spectacular successes in disclosing the underlying genetic basis of a variety of heritable diseases. These successes are exemplifie? by identification of the genes for neurofibromatosIs type 1 and cystic fibrosis, elucidation of tumor sup-
pressor ge~es in vari~us f?rms ofh~ritable cance.rs, a~d det~ction of 
genetic lesIOns resultmg m generahzed connective tissue disorders, 
such as the Marfan syndrome (see, for example, [1 - 3]). In the field 
of molecular dermatology, the genetic bases of a large number of 
cutaneous diseases have also been disclosed (Table I). An example of 
genodermatoses in which the underlying mutations have been 
identified is ~p!~ermolys.is. bullosa (EB),. a group of mechanobullous 
diseases exhibiting fragility of the skin and mucous membranes 
[4,5]. Conventionally, EB has been divided into three major types, 
on the basis of the level of tissue separation as determined by diag-
nostic transmission electron microscopy. It is now known that the 
simplex forms of EB result from discrete mutations in the genes 
encoding the basal keratins, KRT5 and KRT14 [6,7]. As a result, the 
assembly of the intermediate filament network is compromised, 
with subsequent fragility of the basal cells. In addition to mutations 
in the basal keratins in EB simplex, the suprabasal keratins, KRTl 
and KRTI0, have been shown to contain mutations resulting in 
epidermolyti~ hyperkerat?si~ [8] . In th~ junct~onal forms of EB, t~e 
tissue separation occurs wlthm the lamma luclda of the dermal-epi-
dermal basement membrane with accompanying alterations in the 
hemidesmosomes. Recent studies have disclosed distinct mutations 
in the genes encoding laminin 5 (previously known as nicein/ka-
linin), a lamina lucida protein with structural homology to classical 
laminin (Iaminin 1) [9,10] . The dystrophic forms ofEB are charac-
terized by structural or quantitative abnormalities in the anchoring 
fibrils, which consist predominantly, if not exclusively, of type VII 
collagen [5,11]. A number of distinct mutations have recently been 
demonstrated in the type VII collagen gene in both recessively and 
dominantly inherited forms of dystrophic EB [12-15]. 
The efforts to identify mutations in candidate genes in these 
genetic diseases have frequently been guided by mapping of the 
disease locus by genetic linkage analyses, which can establish co-
inheritance of a genetic marker within the human genome and the 
clinical phenotype [16]. Genetic linkage analyses are based on two 
general principles. First, the candidate gene approach is based on 
pre-existing knowledge of the basic biochemical defect either at the 
morphologic or functional level, which can suggest a candidate 
gene(s). If the candidate gene has been cloned and its chromosomal 
location is established, DNA polymorphisms within or near the 
gene locus can be used as markers to follow the inheritance of a 
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specific allele or haplotype in kindreds with the disease [16] . This 
approach has proved successful, for example, in establishing genetic 
linkage between the type VII collagen gene at chromosomal locus 
3p21 and the inheritance of the dystrophic forms ofEB [17,18] . The 
second approach can be used in the absence of an obvious candidate 
gene, and is known as "positional cloning." This approach utilizes 
linkage analyses of up to several hundred polymorphic markers that 
are evenly distributed throughout the human genome [16]. Once 
co-segregation of the inheritance of a marker and the disease is 
established, fine-mapping techniques can narrow the region of the 
chromosome harboring the mutated gene. Pinpointing the mutated 
gene will eventually allow elucidation of the corresponding pro-
tein, with demonstration of specific functions and identification of 
mutations leading to altered expression of the gene. The application 
of positional cloning was instrumental, for example, in identifica-
tion of the novel genes underlying neurofibromatosis type 1 and 
cystic fibrosis . 
The strength of the association between the genetic marker and 
the inheritance of the disease is expressed as a LOD score (Z), which 
reflects the statistical likelihood that the two loci are genetically 
linked and not co-inherited by random chance. The LOD score 
(i.e., logarithm of the odds in favor of linkage) is usually calculated 
in separate families, but the LOD scores can be summed if the 
disease is. li~ely to r~prese~t a mutation in the same gene, as judged 
by the chrncal or histologiC appearance of the phenotype. A maxi-
mum LO D score (Z> 3) indicates odds of 103 , or 1000 to 1 in favor 
of linkage, and is considered to be proof of genetic linkage between 
~he locus and the disease. Alternatively, if the linkage analyses result 
m a LOD score ofless than - 2, the disease locus is considered to be 
excluded from linkage to the marker locus. 
In several cases, genetic linkage analyses have established the 
chromosomal. regi~n harboring the mutation, but the precise gene 
has not been Identified as yet. One example is the Darier's disease 
locus, which was recently mapped to the long arm of human chro-
mosome 1.2, corresponding to the region q23-q24.1 [19,20]. This 
map location for Darier's disease obviously excludes several candi-
date genes t1~at .have been mapped elsewhere in the human genome. 
Thu~, genetic hnkage analyses can be used for exclusion of putative 
candidate genes for certain diseases. 
In this issue, Welsh et af [21] report that Hailey-Hailey disease is 
not allelic to Darier's disease. In other words, the mutations causing 
these two conditions reside in two distinct genes at different loca-
tions within the genome. This study was prompted by certain over-
lapping clinical and histologic features between these two genoder-
matos~s, su~gesting that they might be allelic. The approach of 
these mvestlgators was to utilize polymorphic markers, which are 
known to flank the locus on chromosome 12 to which the Darier's 
disease gene was previously mapped. Using DNA from two large 
families with autosomal dominantly inherited Hailey-Hailey dis-
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Table I. Genetic Basis of Heritable Skin Diseases: Examples of 
Genodermatoses Mapped to Distinct Regions of the Human 
Genome and the Mutated Genes 
Disease 
Epidermolysis 
Bullosa (EB) 
Simplex 
Simplex 
Junctional 
Junctional 
Dystrophic 
Epidermolytic 
hyperkeratosis 
X-linked ichthyosis 
Marfan syndrome 
Ehlers-Danlos 
syndrome (EDS) 
Type IV 
Type VI 
Type VII 
Type IX 
Chromosomal 
Map Location 
12q 
17q 
lq25-32 
lq32 
3p21b 
12q 
17q 
Xp22 
15q15 
2q3l 
Ip36 
17q21 
Xq13 
Mutated Gene/Protein 
KRT5/keratin 5 
KRT14/keratin 14 
LAMB3/fJ3 chain of lam in in 5' 
LAMC2/y2 chain of laminin 5' 
COL7Al/type VII collagen 
KRTI/keratin 1 
KRTI0/keratin 10 
SST/steroid sulfatase 
FBNl/fibrillin 1 
COUAl/type III collagen 
PLOD /lysyl hydroxylase 
COUA1/type I co llagen 
MNK/Mc-l' 
• The fJ3 and y2 chains oflaminin 5 were previously known as the Bland B2 chains of 
nicein/kalinin [22]. 
• Both dominantly and recessively inherited forms of dystrophicEB have been linked 
to COL7AIIocus at 3p21 [23]. 
, EDS type IX (also known as X-linked cutis laxa) is al lelic to the Menkes syndrome 
gene, MNK, which encodes a copper transport ATPase [24). Consequently, the activity 
of lysyl oxidase, a copper dependent enzyme, is reduced in these condirions. 
ease, the investigators were able to clearly exclude the Darier's 
disease gene 1~)Cus in these families. The authors also excluded a 
variety of putative candidate genes, including the type I and II 
keratin genes, loricrin, desmoplakin, and several desmosomal pro-
teins. Several other candidate genes that participate in the keratini-
zation of the epidermis and that have been mapped to distict loci, 
such as the transglutaminase genes, could be examined next. Never-
theless, the authors have decided to perform a genome-wide search 
using the positional cloning approach. To date, 94 polymorphic loci 
have been examined, and the results have been negative thus far 
[21]. However, with the availability of a large number of families 
with multiple affected and unaffected individuals, and with the 
proved success of the positional cloning strategy in other inherited 
diseases, one can be fairly certain that the Hailey-Hailey disease 
locus can eventually be mapped within the human genome. How-
ever, mapping of the gene to a certain region is only the beginning 
of the extensive work involved in fine mapping of the region, even-
tually leading to the identification of the specific gene harboring the 
mutation, and characterization of the putative protein at fault in this 
skin disease. It is also clear that similar approaches are applicable to 
other heritable skin diseases, including pseudoxanthoma elasticum 
and cutis laxa, among others, in which the underlying genetic le-
sions remain undiscovered. 
REFERENCES 
1. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, Puffen-
berger EG, Hamosh A, Nanthakumar EJ, Curristin SM, Stetten G, Meyers DA, 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Francomano CA: Marfan syndrome caused by a recurrent de novo missense 
mutation in the fibrillin gene. Nalllre (Lo"d) 352:337-339, 1991 
2. Gutmann DH, Collins FS: The neurofibromatosis type I gene and its protein 
product, neurofibromin. Nfl/ro" 10:335-343, 1993 
3. MarxJ: New colon cancer gene discovered. Sci",ce 260:751-752,1993 
4. Lin AN, Carter OM: Epidennolysis bullosa. In: Lin AN, Carter DM (cds.). Basic 
a"d e li"ical Aspects. Springer-Verlag, New York, 1992 
5. Uitto J, Christiano AM: Molecular genetics of the cutaneous basement membrane 
zone. Perspectives on epidermolysis bullosa and other blistering skin diseases. 
] eli" IrlVest 90:687 - 692, 1992 
6. Epstein Jr EH: Molecular genetics of epidermolysis bullosa. Scie"ce 256:799 -803, 
1992 
7. Fuchs E: Genetic skin disorders of kerarin. ] Im.est Dermatol 99:671-674, 
1992 
8. DiGiovanna JJ, Bale SJ: Epidermolytic hyperkeratosis: applied molecular genet-
ics.] Invest Dermatoll02:390-394, 1994 
9. Pulkkinen L, Christiano AM, Airerme T, Haakana H, Tryggvason K, Uitto J: 
Mutations in the y2 chain gene (LAMC2) of kalin in/lam in in 5 in thejunctional 
forms of epidennolysis bullosa. Nature Ge'lCt6:293-298, 1994 
10. Aberdam D, Gall iano M-F, Vailly J , Pulkkinen L, Bonifas J, Christiano AM, 
Tryggvason K, Uitto J, Epstein Jr EH, Ortonne J-p, Meneguzzi G: Herlitz's 
junctional epidermolysis bullosa is genetically linked to mutations in the gene 
for the y2 subunit (LAMC2) of nicein/kalinin (laminin 5). Nature Ge"et6:299-
304,1994 
1 \. Burgeson RE: Type VII collagen, anchoring fibrils, and epidermolysis bullosa. 
] ["vest Dermatoll0l:252-255, 1993 
12. Christiano AM, Greenspan OS, Hoffman GG, Zhang X, Tarnai Y, Lin AN, Dietz 
HC, Hovnanian A, Uitto J: A missense mutation in type VlI collagen in rwo 
affected siblings with recessive dystrophic epidermolysis bullosa. Nawre Ge"et 
4:62-66,1993 
13. Hilal L, Rochat A, Duquesnoy P, Blanchet-Bardon C, Wechsler }, Marrin N, 
Christiano A, Barrandon Y, Uitto J, Goossens M, Hovnanian A: A homozy-
gous frameshift mutation in COL7 Al predicting a truncated protein in the 
Hallopeau-Siemens form of recessive dystrophic epidermolysis bullosa. NaW,. 
Gwet5:287-293,1993 
14. Christiano AM, Anhalt G, Gibbons S, Bauer EA, Vitto J: Premature termination 
codons in the type VII collagen gene (COL7Al) underlie severe, mutilating 
recessive dystrophic epidermolysis bullosa. Ge"omics 21:160-168, 1994 
15. Christiano AM, Ryyniinen M, Uitto]: Dominant dystrophic epidemrolysis bul-
losa: identification of a Glycine-to-Serine substitution in the triple-helical do-
main of type VII collagen. Proc Nat! Acad Sci USA 91:3549-3553, 1994 
16. Christiano AM, Vitto J: Polymorphism of the human genome: markers for ge-
netic linkage analysis in heritable diseases of the skin.] bwest DermatoI99:519-
523, 1992 
17. Ryynanen M, Knowlton RG, Parente MG, Chung LC, Chu M-L, Vitto ]: 
Human type VII collagen: genetic linkage of the gene (COL7 AI) on chromo-
some 3 to dOlninant dystrophic epidermolysis bullosa. A m] Human Genet 
49:797-803,1991 
18. Hovnanian A, Duquesnoy P, Blanchet-Bardon C, Knowlton RG, Amselem S, 
Lathrop M, Dubertret L, Uitto], Goossens M: Genetic linkage of recessive 
dystrophic epidermolysis bullosa to the type VII collagen gene.] eli" ["vest 
90:1032-1036,1992 
19. Bashir R, Munro CS, Mason S, Stephenson A, ReesJL, Strachan T : Localization of 
a gene for Darier's disease. H,m, Molec Genet 2:1937 -1939, 1993 
20. Craddock N, DawsonE, Burge S, Parfitt L, Mant B, Roberts Q, DanielsJ, Gill M, 
McGuffin P, PowellJ, Own M: The gene for Darier's disease 1lL1pS to chromo-
some 12q23-q24.1. Hum Molec Gwet2:1941-1943, 1993 
21. WeishEA, IkedaS, Peluso AM, BonifasJM,BarejW, Woodley DT,EpsteinEH: 
Hailey-Hailey disease is not allelic to Darier's disease. ] Irovest Dennatol 
102:992-993,1994 (this issue) 
22. Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, 
Martin GR, Meneguzzi G, Paulsson M, Sanes J, Timpl R, TryggvasoD K, 
Yamada Y, Yurchenko PO: A new nomenclature for Iaminins. Matrix Bioi (in 
press) 
23. Vitro J, Pulkkinen L, Christiano AM: Molecular basis of the dystrophic and 
junctional forms of epidermolysis bullosa: mutations in the type VII collagen 
and kalinin (laminin 5) genes.] b,vest Dermatol (in press) 
24. Levinson B, Gietschier], Vulpe C, Whitney S, Yang S, Packman S: Arc X-linked 
cutis laxa and Menkes disease allelic? Nature Ge"et 3:6, 1993 
